Trial NCT01957644

View at ClinicalTrials.gov 
Org. Study IDs: 1230.33
Secondary IDs: 2013-001290-24

Last trial update was posted on 2019-02-08

MeSH Interventions

Azacitidine

MeSH Conditions

Leukemia Leukemia, Myelomonocytic, Chronic Myelodysplastic Syndromes Preleukemia Syndrome

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

The sponsor discontinued the development of volasertib on 25 Nov 2016 and this trial was discontinued on 16 Dec 2016 for non-clinical reasons. The number of patients enrolled in Part 2 of the study was too small for a meaningful analysis.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID